Cost Effectiveness and Resource Allocation

Papers
(The H4-Index of Cost Effectiveness and Resource Allocation is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong36
The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review26
Third-line multiple myeloma treatment of inpatients in a German cancer center: analysis of potential cost savings due to decreased renal insufficiency25
Comparison of current relative value unit-based prices and utility between common surgical procedures, including orthopedic surgeries, in South Korea24
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in “Boao Lecheng Pilot Zone”24
Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening23
Can integrated care improve the efficiency of hospitals? Research based on 200 Hospitals in China21
Exploration of an alternative reconstructed individual patient data-based approach for budget impact analysis of anticancer drugs21
Economic aspects of prolonged home video-EEG monitoring: a simulation study19
A cost-effectiveness analysis of the combination of serplulimab with chemotherapy for advanced esophageal squamous cell carcinoma: insights from the ASTRUM-007 trial18
Tracking malaria health disbursements by source in Zambia, 2009–2018: an economic modelling study18
In situ breast cancer surgeries in Sweden: lumpectomy or mastectomy?—a cost-effectiveness analysis over a 30-Year period using Markov model17
The economic burden of bipolar disorder: a case study in Southern Iran16
The appearance and increase in the quantity and proportion of the clinical research coordinator’s service fee in drug clinical trial research fund and its impact on trial quality16
Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia15
A review on the evolving environment of medical device real-world evidence regulation on market access in the USA15
Real-world effectiveness of a new powered stapling system with gripping surface technology on the intraoperative clinical and economic outcomes of gastrectomy for gastric cancer15
0.040082931518555